Bringing life-changing therapies to rare disease patients requires expertise, innovation, and a deep understanding of the evolving regulatory landscape. In this expert video, Oxana Iliach, PhD, VP, Regulatory Strategy, shares her insights on the biggest regulatory challenges and opportunities in rare disease drug development—and how innovative approaches can help biopharma companies accelerate approvals, de-risk development, and bring hope to patients faster.
